INVO Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	3.02	0.82	4.16	1.04	1.48	0.49	0.28	0.05	0.01
Revenue Growth (YoY)	267.38%	-80.24%	301.06%	-29.92%	199.41%	75.22%	454.30%	335.46%	-
Cost of Revenue	1.93	0.85	0.15	0.09	0.14	0.09	0.05	0.02	0.01
Gross Profit	1.09	-0.03	4.02	0.95	1.34	0.4	0.23	0.04	0
Selling, General & Admin	7.49	9.98	9.02	6.07	3.13	3.04	0.87	2.15	0.6
Research & Development	0.17	0.54	0.22	0.4	0	0	0	0	0
Other Operating Expenses	0.2	0.08	0	0	0	0	0	0	0
Operating Expenses	7.85	10.6	9.23	6.46	3.13	3.04	0.87	2.15	0.6
Operating Income	-6.77	-10.63	-5.22	-5.51	-1.79	-2.63	-0.64	-2.11	-0.6
Interest Expense / Income	0.93	0.06	1.27	2.84	0.39	0.44	0.02	0.01	0.03
Other Expense / Income	0.31	0.2	0.17	-0	-0.01	-	0.04	-	4.33
Pretax Income	-8.01	-10.89	-6.65	-8.35	-2.17	-3.08	-0.7	-2.12	-4.96
Income Tax	0.03	0	0	0	0	0	0	0	0
Net Income	-8.03	-10.89	-6.65	-8.35	-2.17	-3.08	-0.7	-2.12	-4.96
Shares Outstanding (Basic)	2	1	1	0	0	0	0	0	0
Shares Outstanding (Diluted)	2	1	1	0	0	0	0	0	0
Shares Change	158.35%	14.02%	93.68%	13.08%	5.45%	4.27%	1.52%	8.26%	-
EPS (Basic)	-5.13	-17.97	-12.52	-30.40	-9.00	-12.80	-	-12.80	-25.60
EPS (Diluted)	-5.13	-17.97	-12.52	-30.40	-9.00	-12.80	-	-12.80	-25.60
Free Cash Flow	-5.2	-6.62	-6.48	-4.86	1.31	-0.67	-0.18	-0.34	-0.15
Free Cash Flow Per Share	-3.32	-10.91	-12.20	-17.72	5.38	-2.92	-0.82	-1.56	-0.76
Gross Margin	35.96%	-3.48%	96.51%	91.44%	90.56%	81.72%	81.59%	70.35%	33.19%
Operating Margin	-224.04%	-1292.45%	-125.39%	-531.67%	-120.80%	-532.81%	-226.98%	-4146.12%	-5090.89%
Profit Margin	-266.00%	-1324.81%	-159.97%	-804.73%	-146.43%	-622.22%	-248.87%	-4173.30%	-42426.61%
Free Cash Flow Margin	-172.15%	-804.68%	-155.87%	-468.92%	88.21%	-136.00%	-64.25%	-667.18%	-1297.13%
EBITDA	-6.88	-10.75	-5.22	-5.48	-1.75	-2.63	-0.68	-2.11	-4.92
EBITDA Margin	-227.77%	-1307.83%	-125.45%	-527.94%	-118.50%	-531.76%	-240.47%	-4142.43%	-42104.51%
Depreciation & Amortization	0.2	0.08	0.17	0.03	0.03	0.01	0	0	0.01
EBIT	-7.08	-10.83	-5.38	-5.51	-1.78	-2.63	-0.68	-2.11	-4.93
EBIT Margin	-234.42%	-1317.23%	-129.44%	-531.27%	-120.22%	-532.81%	-241.47%	-4146.12%	-42152.70%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).